OnabotulinumtoxinA (Botox) Nerve Blocks Provide Durable Pain Relief for Men with Chronic Scrotal Pain: A Pilot Open-Label Trial

被引:20
作者
Khambati, Aziz [1 ]
Lau, Susan [2 ]
Gordon, Allan [3 ]
Jarvi, Keith A. [1 ,2 ]
机构
[1] Univ Toronto, Mt Sinai Hosp, Dept Surg, Div Urol, Toronto, ON M5T 3L9, Canada
[2] Univ Toronto, Inst Med Sci, Toronto, ON M5T 3L9, Canada
[3] Mt Sinai Hosp, Wasser Pain Management Ctr, Toronto, ON M5G 1X5, Canada
关键词
Botox; Chronic Scrotal Pain; OnabotulinumtoxinA; PLACEBO-CONTROLLED PHASE; TOXIN TYPE-A; BOTULINUM TOXIN; SPERMATIC CORD; MICROSURGICAL DENERVATION; CHRONIC ORCHIALGIA; DOUBLE-BLIND; MANAGEMENT;
D O I
10.1111/jsm.12707
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
IntroductionChronic scrotal pain (CSP) is a common, often debilitating, condition affecting approximately 4.75% of men. While nerve blocks using local anesthetics usually provide temporary pain relief, there are no publications on the use of longer acting nerve blocks to provide more durable pain relief for men with CSP. AimThe aim of this study was to determine if onabotulinumtoxinA (Botox) cord blocks provide durable pain relief for men with CSP. MethodsIn this pilot open-label study, men with CSP who had failed medical management but experienced temporary pain relief from a standard cord block underwent a cord block with 100U Botox. Main Outcome MeasuresThe outcomes measured were changes 1, 3, and 6 months post-Botox injection in (i) a 10-point visual analog scale (VAS) pain score; (ii) scrotal tenderness on a three-point scale as rated by physical examination; and (iii) the Chronic Epididymitis Symptom Index (CESI) to measure the severity and impact of scrotal pain on men. Paired t-tests were used to compare groups. ResultsEighteen patients with CSP seen between April and September 2013 had Botox injected as a cord block. At the 1-month follow-up, pain reduction was reported by 72% of patients (mean VAS score: 7.36 vs. 5.61, P<0.003), while by physical examination 44 and 34% of the men had either complete or partial resolution of scrotal tenderness. In addition, there was also a significant reduction in CESI scores (22.19 vs. 19.25, P<0.04). At 3 months, 56% had both sustained pain reduction and reduced tenderness based on the VAS score (mean: 7.36 vs. 6.02, P<0.05) and physical exam. The CESI score continued to be significantly lower. Unfortunately, by 6 months, most men had a return to their baseline levels of pain and tenderness. ConclusionsOur pilot study found that Botox cord blocks provide pain reduction for 3 months or more for most men with CSP. Khambati A, Lau S, Gordon A, and Jarvi KA. OnabotulinumtoxinA (Botox) nerve blocks provide durable pain relief for men with chronic scrotal pain: A pilot open-label trial. J Sex Med 2014;11:3072-3077.
引用
收藏
页码:3072 / 3077
页数:6
相关论文
共 29 条
[1]  
Aoki KR, 2003, HEADACHE, V43, pS9
[2]  
Aurora SK, 2010, CEPHALALGIA, V30, P793, DOI 10.1177/0333102410364676
[3]   A Novel Treatment of Chronic Orchialgia [J].
Basal, Seref ;
Ergin, Atila ;
Yildirim, Ibrahim ;
Goktas, Serdar ;
Atim, Abdulkadir ;
Sizlan, Alt ;
Irkilata, Hasan Cem ;
Kurt, Ercan ;
Dayanc, Murat .
JOURNAL OF ANDROLOGY, 2011, 33 (01) :22-26
[4]   Chronic pain in Australia: a prevalence study [J].
Blyth, FM ;
March, LM ;
Brnabic, AJM ;
Jorm, LR ;
Williamson, M ;
Cousins, MJ .
PAIN, 2001, 89 (2-3) :127-134
[5]   Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment [J].
Breivik, H ;
Collett, B ;
Ventafridda, V ;
Cohen, R ;
Gallacher, D .
EUROPEAN JOURNAL OF PAIN, 2006, 10 (04) :287-333
[6]   Laparoscopic testicular denervation for chronic orchalgia [J].
Cadeddu, JA ;
Bishoff, JT ;
Chan, DY ;
Moore, RG ;
Kavoussi, LR ;
Jarrett, TW .
JOURNAL OF UROLOGY, 1999, 162 (03) :733-735
[7]  
Ciftci H., 2010, Current Urology, V4, P67, DOI [DOI 10.1159/000253415, 10.1159/000253415]
[8]   CHRONIC ORCHIALGIA IN THE PAIN PRONE PATIENT - THE CLINICAL PERSPECTIVE [J].
COSTABILE, RA ;
HAHN, M ;
MCLEOD, DG .
JOURNAL OF UROLOGY, 1991, 146 (06) :1571-1574
[9]   ANALYSIS AND MANAGEMENT OF CHRONIC TESTICULAR PAIN [J].
DAVIS, BE ;
NOBLE, MJ ;
WEIGEL, JW ;
FORET, JD ;
MEBUST, WK .
JOURNAL OF UROLOGY, 1990, 143 (05) :936-939
[10]   OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial [J].
Diener, H. C. ;
Dodick, D. W. ;
Aurora, S. K. ;
Turkel, C. C. ;
DeGryse, R. E. ;
Lipton, R. B. ;
Silberstein, S. D. ;
Brin, M. F. .
CEPHALALGIA, 2010, 30 (07) :804-814